ARFNZ Criticizes Health Ministry's Latest E-Cigarette Regulations

Dec.05.2022
ARFNZ Criticizes Health Ministry's Latest E-Cigarette Regulations
New Zealand respiratory fund criticizes Health Department's latest outbreak regulations but advocates reducing tobacco harm instead of attacking e-cigarettes.

The latest outbreak from the Ministry of Health is disappointing, but unfortunately not surprising, according to Nancy Loucas, Executive Coordinator of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), in response to the Asthma and Respiratory Foundation NZ (ARFNZ).


She made the comment after ARFNZ claimed that the Ministry of Health had not achieved a proper balance with New Zealand's e-cigarette regulations.


ARFNZ's exaggerations and unfounded claims about e-cigarettes persist, but in reality, New Zealand has successfully implemented a harm reduction strategy for tobacco, leading to a smoke-free New Zealand by 2025. According to Ms. Loucas, ARFNZ should focus their attacks on combustible cigarettes instead.


CAPHRA was shocked to learn from the latest official statistics that ARFNZ is continuing on the path of new prohibitionism. Earlier this month, it was revealed that New Zealand's smoking rate has dropped from 9.4% of adults smoking daily a year ago to a historic low of 8%.


The Smoke-Free Environment and Regulated Products (Smoked Tobacco) Amendment is currently under parliamentary review. Its aim is to restrict the attractiveness and accessibility of cigarettes.


Ms. Lucas stated that ARFNZ should only be focusing on the Smoke-free Amendment Bill. Instead, they seem determined to continuously undermine and criticize the Ministry of Health's position on e-cigarettes. The issue here is cigarettes, not safer nicotine alternatives that save the lives of thousands of New Zealand smokers every year.


According to CAPHRA, New Zealand's smoke-free and THR policies are being studied and replicated by many other countries. Recently, a parliamentary delegation from Malaysia visited New Zealand to learn how smoking rates were halved in the past decade. New Zealand's regulatory framework is also crucial for recent regulations in the Philippines, and even Thailand is considering creating its own regulations based on New Zealand's model.


We urge the Deputy Minister of Health, Dr. Ayesha Verrall, to continue down the path of Tobacco Harm Reduction (THR), which has been successful in helping adult New Zealand smokers switch to e-cigarettes - a highly effective and harm-reducing smoking cessation tool. It is not the time to be distracted by minor issues.


We also urge ARFNZ to follow science and facts. Let's focus on the real issue - combustible tobacco," said Nancy Loucas.


2FIRSTS will continue to provide ongoing coverage of this topic, with future updates available on the 2FIRSTS app. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
RLX Technology’s Q1 net revenues rose 96.2% year over year, with international business accounting for 72.3% of total revenue. Beyond the headline growth, the results point to deeper globalization: European operations, Nexus supply-chain integration and a broader product portfolio are becoming key signals to watch.
Special Report
May.20
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai
Jeju Health Center to Apply Conventional Tobacco Rules to Liquid E-Cigarettes From April 24
Jeju Health Center to Apply Conventional Tobacco Rules to Liquid E-Cigarettes From April 24
Jeju Health Center said it will apply the same regulations used for conventional tobacco products to all tobacco products, including liquid e-cigarettes, from April 24, while also strengthening public guidance and smoke-free zone management.
Apr.21 by 2FIRSTS.ai
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
The U.S. Food and Drug Administration issued guidance on May 8, 2026, titled “Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization.” The document describes FDA enforcement policies for certain electronic nicotine delivery system products and nicotine pouch products marketed without premarket authorization.
May.09 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14